Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse
Alle Filter löschen

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1022C3(10)
  2. 10C6(2)
  3. 10G10(2)
  4. 1121B(10)
  5. 11B11(4)
  6. 12B5(2)
  7. 148C09(10)
  8. 164#(10)
  9. 16D7(10)
  10. 16E7#(10)
  11. 17E6#(10)
  12. 17F3(4)
  13. 18#(2)
  14. 18A5(10)
  15. 1B4(10)
  16. 1D11.16.8(2)
  17. 1H4(10)
  18. 1H7(10)
  19. 2339#(10)
  20. 23F2G(10)
  21. 25D2(2)
  22. 2B8(10)
  23. 2c3(2)
  24. 2D9(2)
  25. 3(10)
  26. 30-H12(10)
  27. 30C10(10)
  28. 30H12(2)
  29. 31#(10)
  30. 320-587(10)
  31. 356A11(2)
  32. 368D04(2)
  33. 3B3(2)
  34. 3B6(10)
  35. 3C10(2)
  36. 3H9(10)
  37. 4A4(2)
  38. 5C8(10)
  39. 5E5#(10)
  40. 5F9-G4(10)
  41. 6(10)
  42. 60(10)
  43. 6A7(2)
  44. 6D6(2)
  45. 7(10)
  46. 70(2)
  47. 7A9(10)
  48. 7C6(4)
  49. 81C6(10)
  50. 8A4(2)
  51. 8D4-8(2)
  52. 8D5(10)
  53. 9H4(10)
  54. A12(10)
  55. A14(10)
  56. A2(10)
  57. A4(10)
  58. ab324(10)
  59. ABI793(2)
  60. Abituzumab(3)
  61. ABM109(2)
  62. Abrezekimab(2)
  63. Abrilumab(3)
  64. Adalimumab Beta(3)
  65. ADCT-301(10)
  66. ADCT-602(2)
  67. ADG 153(2)
  68. Afasevikumab(3)
  69. Afelimomab(2)
  70. Aflibercept(2)
  71. Alacizumab(2)
  72. ALX148(2)
  73. AMG 811(3)
  74. Anrukinzumab(3)
  75. AO-176(2)
  76. ARGX-112(3)
  77. Aselizumab(3)
  78. Asunercept(2)
  79. AT-1501(2)
  80. AT001(3)
  81. Atacicept(2)
  82. ATG 031(2)
  83. Atrosimab(3)
  84. Avizakimab(3)
  85. B122(2)
  86. B6H12(10)
  87. BAK209B11(2)
  88. Baminercept Alfa(2)
  89. Basiliximab(3)
  90. BAT6004(2)
  91. BD0801(2)
  92. Bectumomab(2)
  93. Belimumab(3)
  94. Benralizumab(3)
  95. Benufutamab(3)
  96. Bermekimab(3)
  97. Bersanlimab(3)
  98. Bevacizumab(3)
  99. Bexmarilimab(3)
  100. Bifikafusp Alfa(2)
  101. Bimekizumab(3)
  102. BION 1301(2)
  103. Bivatuzumab(3)
  104. BlySmAb-1.1(10)
  105. Brazikumab(3)
  106. Briakinumab(3)
  107. Briobacept(2)
  108. Brolucizumab(2)
  109. BT-063(3)
  110. Burfiralimab(2)
  111. C17.8(2)
  112. C2_2E12(2)
  113. Camidanlumab(3)
  114. Camoteskimab(3)
  115. Canakinumab(3)
  116. Cantuzumab(2)
  117. CAT-02-106(2)
  118. CAT-2200(3)
  119. CC-90002(3)
  120. CDP484(3)
  121. CDP571(2)
  122. CDX-0125-TEI(2)
  123. Cendakimab(3)
  124. Certolizumab(2)
  125. Clazakizumab(3)
  126. Clivatuzumab(3)
  127. CMAB008(3)
  128. CMB-401(2)
  129. CNTO 607(3)
  130. Conatumumab(3)
  131. Conbercept(2)
  132. CYT-91000(2)
  133. D1(10)
  134. D2(4)
  135. D8P1C1(2)
  136. Daclizumab(3)
  137. Dapirolizumab(2)
  138. DC101(12)
  139. Dectrekumab(3)
  140. Denosumab(3)
  141. Depemokimab(3)
  142. Dilpacimab(2)
  143. DISC0280(3)
  144. DLX521(2)
  145. Dovanvetmab(2)
  146. Dreg-55(10)
  147. Drozitumab(3)
  148. DS-8273a(3)
  149. Dupilumab(3)
  150. Dusigitumab(3)
  151. Duvakitug(3)
  152. E4#(20)
  153. Ebdarokimab(3)
  154. Efalizumab(3)
  155. Efdamrofusp Alfa(2)
  156. Eflimrufusp Alfa(2)
  157. Eftozanermin Alfa(2)
  158. Elsilimomab(2)
  159. Emapalumab(3)
  160. ENA2(10)
  161. Enavatuzumab(3)
  162. Enlimomab(3)
  163. Enokizumab(3)
  164. Epitumomab cituxetan(2)
  165. Epratuzumab(5)
  166. Eptinezumab(3)
  167. Erlizumab(3)
  168. ESBA 105(3)
  169. Etanercept(2)
  170. Etokimab(3)
  171. Etrolizumab(3)
  172. F16(10)
  173. Faricimab(2)
  174. FD441.8(10)
  175. Fezakinumab(3)
  176. Fletikumab(3)
  177. Fontolizumab(3)
  178. Fremanezumab(3)
  179. Fresolimumab(3)
  180. Frexalimab(3)
  181. G28-8(10)
  182. G544(10)
  183. G6(2)
  184. GAL-F2(2)
  185. Galcanezumab(3)
  186. Gatipotuzumab(3)
  187. Gevokizumab(3)
  188. Golimumab(3)
  189. GSK679586(3)
  190. Gumokimab(3)
  191. Guselkumab(3)
  192. H2L6(3)
  193. H398(10)
  194. H4H10(2)
  195. H5(10)
  196. H52(2)
  197. H6(20)
  198. HB 9579(10)
  199. HFE7A(10)
  200. HM1.24(10)
  201. hMAK195(3)
  202. HMBD-004A(2)
  203. HMBD-004B(2)
  204. HMFG1(10)
  205. HMPL-a83(2)
  206. hRFB4(2)
  207. HuGAL-F2(3)
  208. hum12G8(2)
  209. HuMax-IL15(3)
  210. huS6F1(2)
  211. HW1(10)
  212. IMA-026(3)
  213. IMC-002(2)
  214. IMC-1C11(2)
  215. ImClone 6.64(3)
  216. IMM01(2)
  217. Immurait-Ll2Mab(3)
  218. Inbakicept(2)
  219. Infliximab(3)
  220. Inolimomab(3)
  221. Inotuzumab(3)
  222. Itepekimab(3)
  223. Iv0058(4)
  224. Ivonescimab(2)
  225. Ixekizumab(3)
  226. JCAR018(2)
  227. JES6-1A12(4)
  228. KHK2866(3)
  229. L117/1(2)
  230. L120/12(2)
  231. L120/30(2)
  232. L19-TNF(3)
  233. Latikafusp(2)
  234. LDP-01(2)
  235. Lebrikizumab(3)
  236. Lemzoparlimab(3)
  237. Lenercept(2)
  238. Letaplimab(3)
  239. Letolizumab(2)
  240. Lexatumumab(3)
  241. Licaminlimab(2)
  242. Ligufalimab(3)
  243. Livmoniplimab(2)
  244. LL2(10)
  245. Lutikizumab(2)
  246. LY2525623(3)
  247. LY3016859(2)
  248. M1295(3)
  249. M17/4(12)
  250. M3A1(2)
  251. M3B8(2)
  252. M971(3)
  253. M972(3)
  254. Mab1(10)
  255. Magrolimab(3)
  256. Manfidokimab(3)
  257. Mapatumumab(3)
  258. MEDI 5117(3)
  259. MEDI2045(3)
  260. MEDI3185(2)
  261. MEDI3622(2)
  262. Mepolizumab(3)
  263. Metelimumab(3)
  264. MIAP410(2)
  265. Mirikizumab(3)
  266. MO82(2)
  267. MOR101(2)
  268. MOR102(2)
  269. Moxetumomab(2)
  270. MP5-20F3(2)
  271. MR-1(2)
  272. MR1/MR-1(10)
  273. N178A/9(2)
  274. N212/17(2)
  275. N212/7(2)
  276. N275/14(2)
  277. N295B/66(2)
  278. N324/2(2)
  279. N384/63(2)
  280. N39B/8(2)
  281. N4/15(2)
  282. N4/49(2)
  283. N83/48(2)
  284. Nacolomab(2)
  285. Natalizumab(3)
  286. Navicixizumab(2)
  287. Neihulizumab(3)
  288. Nerelimomab(3)
  289. Netakimab(3)
  290. NI-1701(2)
  291. NIS793(3)
  292. NOK1/NOK-1(10)
  293. NOK2/NOK-2(10)
  294. Odulimomab(3)
  295. Olamkicept(2)
  296. Olinvacimab(3)
  297. Olokizumab(3)
  298. Ontamalimab(3)
  299. Ontorpacept(2)
  300. Opinercept(2)
  301. OV52.24(10)
  302. Ozoralizumab(2)
  303. P4D2(10)
  304. Pankomab(3)
  305. Parsatuzumab(3)
  306. Pascolizumab(3)
  307. Pateclizumab(3)
  308. PC-61.5.3(2)
  309. PC61/PC61.5.3(10)
  310. Pemtumomab(2)
  311. Perakizumab(3)
  312. PF-03475952(2)
  313. Pinatuzumab(3)
  314. Placulumab(2)
  315. Pritumumab(3)
  316. PS/2(2)
  317. PTX25(10)
  318. Pulocimab(2)
  319. R310(2)
  320. R4-6A2(2)
  321. R6N(10)
  322. RA8(2)
  323. Rademikibart(3)
  324. Radretumab(2)
  325. Ramucirumab(3)
  326. Ranibizumab(2)
  327. REGN1909(2)
  328. Remtolumab(2)
  329. Reslizumab(3)
  330. RFB-4(10)
  331. RG7356(2)
  332. Rilonacept(2)
  333. Risankizumab(3)
  334. RO5458640(3)
  335. RO7296682(2)
  336. Romilkimab(2)
  337. Rovelizumab(2)
  338. Rozipafusp alfa(2)
  339. RTX-003(2)
  340. RTX-CD47(2)
  341. Ruplizumab(3)
  342. S4B6(2)
  343. S4B6-1(2)
  344. SAA0004(20)
  345. SAA0008(10)
  346. SAA0019(10)
  347. SAA0020(10)
  348. SAA0025(10)
  349. SAA0026(10)
  350. SAA0040(10)
  351. SAA0046(10)
  352. SAA0047(10)
  353. SAA0065(10)
  354. SAA0067(10)
  355. SAA0068(10)
  356. SAA0075(10)
  357. SAA0079(10)
  358. SAA0080(10)
  359. SAA0081(10)
  360. SAA0083(10)
  361. SAA0084(10)
  362. SAA0085(10)
  363. SAA0112(10)
  364. SAA0147(10)
  365. SAA0173(10)
  366. SAA0196(2)
  367. SAA0239(2)
  368. SAA0266(2)
  369. SAA0281(2)
  370. SAA0309(2)
  371. SAA0312(10)
  372. SAA0366(10)
  373. SAA0367(10)
  374. SAA0368(10)
  375. SAA0369(10)
  376. SAA0370(10)
  377. SAA0371(10)
  378. SAA0372(10)
  379. SAA0373(10)
  380. SAA0374(10)
  381. SAA0375(10)
  382. SAA0377(10)
  383. SAA0378(10)
  384. SAA0381(10)
  385. SAA0382(10)
  386. SAA0383(10)
  387. SAA0384(10)
  388. SAA0386(10)
  389. SAA0387(10)
  390. SAA0389(10)
  391. SAA0390(10)
  392. SAA0391(10)
  393. SAA0392(10)
  394. SAA0393(10)
  395. SAA0394(10)
  396. SAA0395(10)
  397. SAA0414(10)
  398. SAA0415(10)
  399. SAA0416(10)
  400. SAA0421(10)
  401. SAA0423(10)
  402. SAA0432(10)
  403. SAA0436(10)
  404. SAA0437(10)
  405. SAA0440(10)
  406. SAA0442(10)
  407. SAA0443(10)
  408. SAA0446(10)
  409. SAA0447(10)
  410. SAA0453(10)
  411. SAA0483(10)
  412. SAA0511(10)
  413. SAA0513(10)
  414. SAA0549(10)
  415. SAA0763(10)
  416. SAA0768(2)
  417. SAA0806(10)
  418. SAA0815(10)
  419. SAA1383(10)
  420. SAA1403(10)
  421. SAA1413(10)
  422. SAA1487(10)
  423. SAA1992(10)
  424. SAA2157(10)
  425. SAA2180(10)
  426. SAA2212(10)
  427. SAA2216(10)
  428. SAA2219(10)
  429. SAR-566658(2)
  430. SAR113244(3)
  431. SAR428926(3)
  432. sB24M(2)
  433. Secukinumab(3)
  434. SG404(2)
  435. SGN CD47M(2)
  436. Sibeprenlimab(3)
  437. Siltuximab(3)
  438. Simridarlimab(2)
  439. Sirukumab(3)
  440. SM06(2)
  441. SM3(2)
  442. Sontuzumab(3)
  443. SRF231(2)
  444. SRK-181(3)
  445. SSS-23(10)
  446. ST2146(10)
  447. Stapokibart(3)
  448. STI-003(2)
  449. STI-6643(2)
  450. Suciraslimab(2)
  451. SWA11(10)
  452. T24/31(10)
  453. TAB004(2)
  454. Tabalumab(3)
  455. Tanibirumab(2)
  456. Tarcocimab(2)
  457. TAS266(4)
  458. TAY018(2)
  459. Temtokibart(3)
  460. Tenatumomab(2)
  461. TI-061(2)
  462. Tibulizumab(2)
  463. Tigatuzumab(3)
  464. Tildrakizumab(3)
  465. Tilogotamab(3)
  466. TJ-C4GM(2)
  467. Toralizumab(2)
  468. Torudokimab(3)
  469. Tozorakimab(3)
  470. TQB 2928(2)
  471. Tralokinumab(3)
  472. TTI-621(2)
  473. TTI-622(2)
  474. Tulisokibart(3)
  475. Ulocuplumab(3)
  476. Urabrelimab(3)
  477. Ustekinumab(3)
  478. VAK-694(2)
  479. Vanucizumab(2)
  480. Varisacumab(3)
  481. VB6(10)
  482. VB6-008(2)
  483. Vedolizumab(3)
  484. VFF-18(10)
  485. VGX100(3)
  486. VIS-649(10)
  487. Vopikitug(3)
  488. Vulinacimab(3)
  489. Vunakizumab(3)
  490. Vx-1004(2)
  491. Xeligekimab(2)
  492. Xentuzumab(3)
  493. XmAb 5592(3)
  494. XMG1.2(4)
  495. XOMA 089(2)
  496. XT3.11(2)
  497. YT33(2)
  498. Ziltivekimab(3)
  499. ZL-1201(2)
Applications
Isotype

Cell Biology

5419 Artikel

pro Seite

Seite:
  1. 135
  2. 136
  3. 137
  4. 138
  5. 139
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Research Grade Mirikizumab Biosimilars Mirikizumab Hu ANSY-DHJ63105-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Etokimab Biosimilars Etokimab Hu ANSY-DHB74001-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Itepekimab Biosimilars Itepekimab Hu ANSY-DHB74002-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Fontolizumab Biosimilars Fontolizumab Hu ANSY-DHB95402-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Afelimomab Afelimomab Hu Mouse ANSY-DHB94405-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Nerelimomab Biosimilars Nerelimomab Hu Mouse ANSY-DHB94406-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Placulumab Placulumab Hu Human ANSY-DHB94407-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Ozoralizumab Ozoralizumab Hu ANSY-DHB94408-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Fresolimumab Biosimilars Fresolimumab Hu Human ANSY-DHB91601-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Metelimumab Biosimilars Metelimumab Hu Human ANSY-DHB91602-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Xentuzumab Biosimilars Xentuzumab Hu ANSY-DHC12001-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Dusigitumab Biosimilars Dusigitumab Hu Human ANSY-DHC12002-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Varisacumab Biosimilars Varisacumab Hu Human ANSY-DHD12604-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Pateclizumab Biosimilars Pateclizumab Hu ANSY-DHB94301-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Odulimomab Biosimilars Odulimomab Hu Mouse ANSY-DHD41002-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Erlizumab Biosimilars Erlizumab Hu ANSY-DHC13101-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Rovelizumab Rovelizumab Hu ANSY-DHC13102-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Epratuzumab Biosimilars Epratuzumab Hu ANSY-DHD38503-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Bectumomab Bectumomab Hu Mouse ANSY-DHD38504-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human CD22 Antibody (Immurait-­Ll2Mab) Antibody Monoclonal Immurait-Ll2Mab Hu Mouse ANSY-DHD38505-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Pinatuzumab Biosimilars Pinatuzumab Hu ANSY-DHD38506-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Inolimomab Biosimilars Inolimomab Hu Mouse ANSY-DHB95804-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Bivatuzumab Biosimilars Bivatuzumab Hu ANSY-DHD14801-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Urabrelimab Biosimilars Urabrelimab Hu Human ANSY-DHG17602-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Etrolizumab Biosimilars Etrolizumab Hu ANSY-DHC98803-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Name Preis
Research Grade Mirikizumab Anmelden Research Grade Mirikizumab
Typ Biosimilars
Clone Mirikizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Etokimab Anmelden Research Grade Etokimab
Typ Biosimilars
Clone Etokimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Itepekimab Anmelden Research Grade Itepekimab
Typ Biosimilars
Clone Itepekimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Fontolizumab Anmelden Research Grade Fontolizumab
Typ Biosimilars
Clone Fontolizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Afelimomab Anmelden Research Grade Afelimomab
Typ
Clone Afelimomab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Nerelimomab Anmelden Research Grade Nerelimomab
Typ Biosimilars
Clone Nerelimomab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Placulumab Anmelden Research Grade Placulumab
Typ
Clone Placulumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Ozoralizumab Anmelden Research Grade Ozoralizumab
Typ
Clone Ozoralizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Fresolimumab Anmelden Research Grade Fresolimumab
Typ Biosimilars
Clone Fresolimumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Metelimumab Anmelden Research Grade Metelimumab
Typ Biosimilars
Clone Metelimumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Xentuzumab Anmelden Research Grade Xentuzumab
Typ Biosimilars
Clone Xentuzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Dusigitumab Anmelden Research Grade Dusigitumab
Typ Biosimilars
Clone Dusigitumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Varisacumab Anmelden Research Grade Varisacumab
Typ Biosimilars
Clone Varisacumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Pateclizumab Anmelden Research Grade Pateclizumab
Typ Biosimilars
Clone Pateclizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Odulimomab Anmelden Research Grade Odulimomab
Typ Biosimilars
Clone Odulimomab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Erlizumab Anmelden Research Grade Erlizumab
Typ Biosimilars
Clone Erlizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Rovelizumab Anmelden Research Grade Rovelizumab
Typ
Clone Rovelizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Epratuzumab Anmelden Research Grade Epratuzumab
Typ Biosimilars
Clone Epratuzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Bectumomab Anmelden Research Grade Bectumomab
Typ
Clone Bectumomab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human CD22 Antibody (Immurait-­Ll2Mab) Anmelden Research Grade Anti-Human CD22 Antibody (Immurait-Ll2Mab)
Typ Antibody Monoclonal
Clone Immurait-Ll2Mab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Pinatuzumab Anmelden Research Grade Pinatuzumab
Typ Biosimilars
Clone Pinatuzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Inolimomab Anmelden Research Grade Inolimomab
Typ Biosimilars
Clone Inolimomab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Bivatuzumab Anmelden Research Grade Bivatuzumab
Typ Biosimilars
Clone Bivatuzumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Urabrelimab Anmelden Research Grade Urabrelimab
Typ Biosimilars
Clone Urabrelimab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Etrolizumab Anmelden Research Grade Etrolizumab
Typ Biosimilars
Clone Etrolizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar

5419 Artikel

pro Seite

Seite:
  1. 135
  2. 136
  3. 137
  4. 138
  5. 139
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top